Literature DB >> 9225801

Normal brain perfusion pattern of technetium-99m-ethylcysteinate dimer in children.

C Schiepers1, A Verbruggen, P Casaer, M De Roo.   

Abstract

UNLABELLED: The purpose of this study was to assess the normal perfusion pattern of the pediatric brain with 99mTc-ethylcysteinate dimer (99mTc-ECD).
METHODS: Tomographic imaging was performed with a dedicated system with high sensitivity and resolution. Sixteen children, referred for brain imaging in the workup of seizure disorder, were included since they turned out negative after a 1-yr follow-up. A standardized brain presentation was obtained after reslicing and reorienting of the three-dimensional volumetric dataset.
RESULTS: Quantitative analysis did not reveal significant left-right uptake differences per patient. Three age clusters were investigated that showed differences in regional uptake, mainly a relatively increased uptake in basal ganglia, visual and motor cortex. An uptake ratio or perfusion index was calculated after normalization. Normal limits were established for the children in the three groups.
CONCLUSION: Technetium-99m-ECD is a safe agent for children and should be the radiopharmaceutical of choice for brain perfusion studies because of favorable radiation dosimetry and stability. The age dependence of perfusion necessitates a database comparison before concluding that the observed perfusion pattern is normal.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225801

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  2 in total

1.  Normal cerebral FDG uptake during childhood.

Authors:  Kevin London; Robert Howman-Giles
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-12-10       Impact factor: 9.236

2.  Diagnostic use of neuro-spect quantified with 99mTc-ECD a model based on normal data.

Authors:  Belmonte Juarez Marroni; Sabine Possa Marroni; Caroline Muller Mayer; Betina R Braga
Journal:  Dement Neuropsychol       Date:  2013 Oct-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.